Cabio Biotech (China) Market Value
| 688089 Stock | 17.84 0.94 5.01% |
| Symbol | Cabio |
Cabio Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cabio Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cabio Biotech.
| 11/06/2024 |
| 01/05/2025 |
If you would invest 0.00 in Cabio Biotech on November 6, 2024 and sell it all today you would earn a total of 0.00 from holding Cabio Biotech Wuhan or generate 0.0% return on investment in Cabio Biotech over 60 days. Cabio Biotech is related to or competes with CIMC Vehicles, Changchun Engley, Quectel Wireless, Guangzhou Automobile, Jinhe Biotechnology, and Haima Automobile. Cabio Biotech is entity of China. It is traded as Stock on SHG exchange. More
Cabio Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cabio Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cabio Biotech Wuhan upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.49 | |||
| Information Ratio | 0.0483 | |||
| Maximum Drawdown | 32.7 | |||
| Value At Risk | (7.58) | |||
| Potential Upside | 8.0 |
Cabio Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cabio Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cabio Biotech's standard deviation. In reality, there are many statistical measures that can use Cabio Biotech historical prices to predict the future Cabio Biotech's volatility.| Risk Adjusted Performance | 0.051 | |||
| Jensen Alpha | 0.2688 | |||
| Total Risk Alpha | 0.1899 | |||
| Sortino Ratio | 0.0472 | |||
| Treynor Ratio | 1.23 |
Cabio Biotech Wuhan Backtested Returns
Cabio Biotech Wuhan secures Sharpe Ratio (or Efficiency) of -0.0556, which signifies that the company had a -0.0556% return per unit of standard deviation over the last 3 months. Cabio Biotech Wuhan exposes thirty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cabio Biotech's mean deviation of 3.41, and Risk Adjusted Performance of 0.051 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.22, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Cabio Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding Cabio Biotech is expected to be smaller as well. At this point, Cabio Biotech Wuhan has a negative expected return of -0.26%. Please make sure to confirm Cabio Biotech's downside deviation, standard deviation, and the relationship between the semi deviation and coefficient of variation , to decide if Cabio Biotech Wuhan performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.50 |
Modest predictability
Cabio Biotech Wuhan has modest predictability. Overlapping area represents the amount of predictability between Cabio Biotech time series from 6th of November 2024 to 6th of December 2024 and 6th of December 2024 to 5th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cabio Biotech Wuhan price movement. The serial correlation of 0.5 indicates that about 50.0% of current Cabio Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.5 | |
| Spearman Rank Test | -0.33 | |
| Residual Average | 0.0 | |
| Price Variance | 2.2 |
Cabio Biotech Wuhan lagged returns against current returns
Autocorrelation, which is Cabio Biotech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cabio Biotech's stock expected returns. We can calculate the autocorrelation of Cabio Biotech returns to help us make a trade decision. For example, suppose you find that Cabio Biotech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Cabio Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cabio Biotech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cabio Biotech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cabio Biotech stock over time.
Current vs Lagged Prices |
| Timeline |
Cabio Biotech Lagged Returns
When evaluating Cabio Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cabio Biotech stock have on its future price. Cabio Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cabio Biotech autocorrelation shows the relationship between Cabio Biotech stock current value and its past values and can show if there is a momentum factor associated with investing in Cabio Biotech Wuhan.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Cabio Stock
Cabio Biotech financial ratios help investors to determine whether Cabio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cabio with respect to the benefits of owning Cabio Biotech security.